EVOKE PHARMA, INC. Other Nonoperating Income (Expense)
EVOKE PHARMA, INC. reported Other Nonoperating Income (Expense) of -$18.52 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2025-11-13
- EVOKE PHARMA, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$18.52K.
- EVOKE PHARMA, INC. other nonoperating income (expense) for the quarter ending 2025-06-30 was -$12.12K.
- EVOKE PHARMA, INC. other nonoperating income (expense) for the quarter ending 2025-03-31 was -$4.43K.
- EVOKE PHARMA, INC. other nonoperating income (expense) for the quarter ending 2024-12-31 was $932.00.
- EVOKE PHARMA, INC. other nonoperating income (expense) for fiscal 2024 was -$148.06K.
- EVOKE PHARMA, INC. other nonoperating income (expense) for fiscal 2023 was -$361.40K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$18.52K 10-Q · filed 2025-11-13 | -$30.64K derived: sum of 2 quarters · filed 2025-11-13 | -$35.08K 10-Q · filed 2025-11-13 | -$34.15K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$12.12K 10-Q · filed 2025-08-14 | -$16.56K 10-Q · filed 2025-08-14 | -$15.63K derived: sum of 3 quarters · filed 2025-08-14 | -$42.36K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | -$4.43K 10-Q · filed 2025-05-13 | -$3.50K derived: sum of 2 quarters · filed 2025-05-13 | -$30.24K derived: sum of 3 quarters · filed 2025-11-13 | -$73.89K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $932.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$25.80K derived: sum of 2 quarters · filed 2025-11-13 | -$69.46K derived: sum of 3 quarters · filed 2025-11-13 | -$148.06K 10-K · filed 2025-03-13 |
| 2024-09-30 | -$26.73K 10-Q · filed 2025-11-13 | -$70.39K derived: sum of 2 quarters · filed 2025-11-13 | -$148.99K 10-Q · filed 2025-11-13 | -$248.47K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$43.66K 10-Q · filed 2025-08-14 | -$122.26K 10-Q · filed 2025-08-14 | -$221.74K derived: sum of 3 quarters · filed 2025-08-14 | -$312.21K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$78.60K 10-Q · filed 2025-05-13 | -$178.08K derived: sum of 2 quarters · filed 2025-05-13 | -$268.55K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2023-12-31 | -$99.48K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$189.95K derived: sum of 2 quarters · filed 2025-03-13 | -$361.40K 10-K · filed 2025-03-13 | |
| 2023-09-30 | -$90.47K 10-Q · filed 2024-11-07 | -$261.92K 10-Q · filed 2024-11-07 |